Want to see HK:2158 full AI Analyst Report?
2158 Stock Chart & Stats
HK$5.58
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$5.58
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$2.73 - HK$7.05
Previous CloseN/A
Volume5.15M
Average Volume (3M)1.99M
Market Cap
HK$3.07B
Enterprise ValueHK$3.05B
Total Cash (Recent Filing)HK$2.22B
Total Debt (Recent Filing)HK$71.09M
Price to Earnings (P/E)37.3
Beta1.81
Next Earnings
Nov 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.39%
Share Statistics
EPS (TTM)0.07
Shares Outstanding1,072,892,600
10 Day Avg. Volume2,010,930
30 Day Avg. Volume1,990,840
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)1.25
Price to Sales (P/S)5.73
P/FCF Ratio-87.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.08
Revenue Forecast (FY)HK$972.31M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthPositive revenue growth indicates continued demand for Yidu Tech’s healthcare data, AI, and analytics offerings. If sustained, expanding customer activity can improve operating leverage, support broader platform adoption, and strengthen the company’s position across pharmaceutical and healthcare-provider markets.
Return To ProfitabilityThe return to positive net income and an approximately 8.9% net margin represents a meaningful improvement from losses in 2021–2024. This recovery provides evidence that the business model can generate accounting earnings and creates a stronger base for continued investment in data and AI capabilities.
Low Financial LeverageVery low leverage materially reduces refinancing and solvency risk while preserving financial flexibility. A stable equity base gives Yidu Tech greater capacity to fund product development, absorb business volatility, and pursue healthcare data or AI opportunities without relying heavily on additional borrowing.
Bears Say
Negative Core Operating EarningsNegative operating profit and EBITDA show that reported net profitability is not yet supported by sustained earnings from core operations. Until operating earnings turn consistently positive, the company may have limited ability to convert revenue growth into durable operating returns and self-funded expansion.
Volatile Cash GenerationThe shift to positive operating and free cash flow is encouraging, but the preceding multi-year cash burn and sharp 2026 decline versus the prior year indicate inconsistent cash generation. This volatility can constrain investment planning and makes the durability of recent earnings less certain.
Low Capital EfficiencySeveral years of negative shareholder returns followed by only modest improvement suggest that capital has not yet been deployed efficiently. Low returns can limit the long-term value created from the company’s equity base, even if reported earnings and revenue begin to recover.
Yidu Tech, Inc. News
2158 FAQ
What was Yidu Tech, Inc.’s price range in the past 12 months?
Yidu Tech, Inc. lowest stock price was HK$2.73 and its highest was HK$7.05 in the past 12 months.
What is Yidu Tech, Inc.’s market cap?
Yidu Tech, Inc.’s market cap is HK$3.07B.
When is Yidu Tech, Inc.’s upcoming earnings report date?
Yidu Tech, Inc.’s upcoming earnings report date is Nov 20, 2026 which is in 27 days.
How were Yidu Tech, Inc.’s earnings last quarter?
Yidu Tech, Inc. released its earnings results on Jun 29, 2026. The company reported HK$0.094 earnings per share for the quarter.
Is Yidu Tech, Inc. overvalued?
According to Wall Street analysts Yidu Tech, Inc.’s price is currently Overvalued.
Does Yidu Tech, Inc. pay dividends?
Yidu Tech, Inc. pays a Notavailable dividend of HK$0.04 which represents an annual dividend yield of 1.39%. See more information on Yidu Tech, Inc. dividends here
What is Yidu Tech, Inc.’s EPS estimate?
Yidu Tech, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yidu Tech, Inc. have?
Yidu Tech, Inc. has 1,072,892,600 shares outstanding.
What happened to Yidu Tech, Inc.’s price movement after its last earnings report?
Yidu Tech, Inc. reported an EPS of HK$0.094 in its last earnings report. Following the earnings report the stock price went up 6.421%.
Which hedge fund is a major shareholder of Yidu Tech, Inc.?
Currently, no hedge funds are holding shares in HK:2158
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yidu Tech, Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.84%
12-Months-Change
Fundamentals
Return on Equity
1.88%
Trailing 12-Months
Asset Growth
-2.66%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Yidu Tech, Inc.
Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.
Technical Analysis
Ping An Healthcare and Technology Company
―
Kindstar Globalgene Technology, Inc.
―
Medlive Technology Co., Ltd.
―
NEUSOFT XIKANG HOLDINGS INC.
―
Xunfei Healthcare Technology Co., Ltd.
―